228 related articles for article (PubMed ID: 12560464)
1. Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesions.
Mason GI; Hamburger J; Bowman S; Matthews JB
Mol Pathol; 2003 Feb; 56(1):52-9. PubMed ID: 12560464
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome.
Koski H; Konttinen YT; Hietanen J; Tervo T; Malmström M
J Rheumatol; 1997 Oct; 24(10):1930-5. PubMed ID: 9330934
[TBL] [Abstract][Full Text] [Related]
3. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome).
Ogawa N; Dang H; Lazaridis K; McGuff HS; Aufdemorte TB; Talal N
J Interferon Cytokine Res; 1995 Sep; 15(9):759-67. PubMed ID: 8536103
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 2 in labial salivary glands in Sjögren's syndrome.
Koski H; Konttinen YT; Gu XH; Hietanen J; Malmström M
Ann Rheum Dis; 1995 Sep; 54(9):744-7. PubMed ID: 7495347
[TBL] [Abstract][Full Text] [Related]
5. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
6. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
7. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome.
Laine M; Virtanen I; Salo T; Konttinen YT
Arthritis Rheum; 2004 Dec; 50(12):3968-73. PubMed ID: 15593200
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome.
Manganelli P; Quaini F; Andreoli AM; Lagrasta C; Pilato FP; Zuccarelli A; Monteverdi R; D'Aversa C; Olivetti G
J Rheumatol; 1997 Aug; 24(8):1552-7. PubMed ID: 9263150
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients.
Nakamura H; Koji T; Tominaga M; Kawakami A; Migita K; Kawabe Y; Nakamura T; Shirabe S; Eguchi K
Clin Exp Immunol; 1998 Oct; 114(1):106-12. PubMed ID: 9764611
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
11. CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases.
Ohlsson M; Szodoray P; Loro LL; Johannessen AC; Jonsson R
Scand J Immunol; 2002 Dec; 56(6):561-71. PubMed ID: 12472667
[TBL] [Abstract][Full Text] [Related]
12. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands.
Kizu Y; Sakurai H; Katagiri S; Shinozaki N; Ono M; Tsubota K; Saito J
J Clin Pathol; 1996 Sep; 49(9):728-32. PubMed ID: 9038756
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.
McCartney-Francis NL; Mizel DE; Redman RS; Frazier-Jessen M; Panek RB; Kulkarni AB; Ward JM; McCarthy JB; Wahl SM
J Immunol; 1996 Aug; 157(3):1306-12. PubMed ID: 8757639
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of insulin-like growth factor-I in the labial salivary glands of patients with Sjögren's syndrome.
Markopoulos AK; Poulopoulos AK; Kayavis I; Papanayotou P
Oral Dis; 2000 Jan; 6(1):31-4. PubMed ID: 10673785
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
17. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome.
Ogawa N; Kawanami T; Shimoyama K; Ping L; Sugai S
Clin Immunol; 2004 Sep; 112(3):235-8. PubMed ID: 15308116
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of members of the transforming growth factor (TGF)-beta superfamily in normal human salivary glands and pleomorphic adenomas.
Kusafuka K; Yamaguchi A; Kayano T; Takemura T
J Oral Pathol Med; 2001 Aug; 30(7):413-20. PubMed ID: 11488419
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome salivary gland immunopathology: increased laminin expression precedes lymphocytic infiltration.
McArthur CP; Daniels PJ; Kragel P; Howard PF; Julian L
J Autoimmun; 1997 Feb; 10(1):59-65. PubMed ID: 9080300
[TBL] [Abstract][Full Text] [Related]
20. Role of the mTOR pathway in minor salivary gland changes in Sjogren's syndrome and systemic sclerosis.
Soypaçacı Z; Gümüş ZZ; Çakaloğlu F; Özmen M; Solmaz D; Gücenmez S; Gercik Ö; Akar S
Arthritis Res Ther; 2018 Aug; 20(1):170. PubMed ID: 30075746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
